Please login to the form below

Not currently logged in

Changing Landscape: Hoe Life Sciences Companies can Respond to the Latest Brexit Signals=

Brexit means Life Science companies operating in the UK and Europe are having to rapidly respond to a changing but still uncertain landscape.  The lack of clarity in trade and regulation for the sector means life science companies need to make multiple risk assessments and plans for a number of scenarios.

Our webinar will see experts from EY give their insights on how big and small companies in the sector can read the Brexit signals and best prepare their business.

Join EY (global leader in assurance, tax, transaction and advisory services) in association with PMGroup to discuss the changing landscape.

The webinar will consider these practical steps:

  • How to respond to potential regulatory changes e.g., Market Authorisation, Quality Release
  • Effectively navigate a customs border
  • Mitigate disruption to clinical trials and business operations *Use Brexit to tap into new opportunities

Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...